William Heisel, former investigative reporter for the Los Angeles Times, writes about investigative health reporting. He is currently the director of global engagement at the Institute for Health Metrics and Evaluation.
My former colleague at the Los Angeles Times, Myron Levin, played an important role in unearthing new information about cell phone use and car accidents.
Medical malpractice cases can live or die on the testimony of an expert witness. Defense
attorneys will go after the expert's credentials with every tool in their kit.
One would think that plaintiff's attorneys suing the federal government on behalf of a
patient would make sure they had a doctor with impeccable experience ready to take the stand and bolster the patient's case.
Instead, they hired Dr. Alex T. Zakharia.
Let's assume that Dr. Conrad Murray did not kill Michael Jackson.
What drives someone with a strong scientific reputation to cut a secret deal with a drug company for ghostwriting help just to have one more paper published?
Dr. Adriane Fugh-Berman has become the go-to source for comments on how drug companies have been using ghostwriters to inject marketing messages into the medical literature, a controversy that prompted powerful Sen. Charles Grassley, R-Iowa, to send a letter on Aug. 11 to the National Institutes of Health asking, among other things, "What is the current NIH policy on ghostwriting with regards to NIH researchers?"
If DesignWrite, the medical communications firm that has been ghostwriting articles on behalf of drug giant Wyeth, were an elementary school student, it would have a stack of papers heavy with gold stars.
Dr. Gloria Bachmann, the associate dean for women's health at the Robert Wood Johnson Medical School in New Brunswick, N.J., told the company it had written an "an A plus article" after it wrote a review article that Bachmann agreed to sign. The article appeared with hardly a word changed in The Journal of Reproductive Medicine.
Dr. Adriane Fugh-Berman is the principal investigator of PharmedOut, an educational campaign aimed at showing physicians how marketing influences their prescribing decisions. Originally funded by the Attorney General Consumer and Prescriber Education Grant, PharmedOut, among other things, offers continuing medical education to doctors, allowing them to earn credits without taking courses funded by drug or device companies.